Hydroxychloroquine (Plaquenil) for Lupus: What Every Patient Should Know in 2026

The Cornerstone of Lupus Treatment

If you have lupus, chances are hydroxychloroquine (brand name Plaquenil) is either already in your medicine cabinet or has come up in conversation with your rheumatologist. It is one of the most widely prescribed medications for systemic lupus erythematosus (SLE) and has been a foundational part of treatment for decades.

But despite being so common, many patients still have questions about how it works, what the risks are, and why their doctor insists they keep taking it even when they feel fine.

Here is what you should know heading into 2026.

How Hydroxychloroquine Works

Hydroxychloroquine is an antimalarial drug that was discovered to have powerful effects on the immune system. In lupus, it helps by:

• Reducing inflammation throughout the body
• Lowering the frequency and severity of flares
• Protecting organs — particularly the kidneys and heart — from long-term damage
• Decreasing the risk of blood clots, which lupus patients face at higher rates
• Improving survival rates — multiple studies show lupus patients on hydroxychloroquine live longer

It does not suppress the immune system the way drugs like mycophenolate or cyclophosphamide do. Instead, it modulates the immune response, which is why the side effect profile is relatively mild compared to other lupus medications.

Dosing: The Weight-Based Standard

Current guidelines recommend dosing hydroxychloroquine based on your actual body weight, not a flat dose. The standard is:

• No more than 5 mg per kilogram of actual body weight per day
• For most patients, this works out to 200-400 mg daily
• Some rheumatologists prescribe 200 mg for smaller patients and 400 mg (split into two doses) for others

The move to weight-based dosing came after research showed that the older standard of 400 mg for everyone led to higher rates of eye toxicity in smaller patients. If your doctor has not reviewed your dose relative to your weight recently, it is worth asking about.

Eye Monitoring: The One Risk You Need to Take Seriously

The most talked-about side effect of hydroxychloroquine is retinal toxicity — damage to the retina that can affect your vision. Here is the reality:

• The risk is very low in the first five years of use (under 1%)
• After 10 years of use, the risk increases to roughly 2-3%
• After 20 years, the cumulative risk can reach 10-15% depending on dosing

Screening schedule

• Baseline eye exam within the first year of starting the medication
• Annual screening with OCT (optical coherence tomography) starting after 5 years of use, or sooner if you have risk factors
• Risk factors include kidney disease, higher doses, tamoxifen use, and pre-existing macular disease

Early detection through regular screening means your doctor can stop the medication before any significant vision changes occur. Do not skip your eye exams. This is one of the most important things you can do while taking hydroxychloroquine.

Pregnancy and Hydroxychloroquine

One of the remarkable things about hydroxychloroquine is that it is considered safe during pregnancy and breastfeeding. In fact, most rheumatologists recommend that pregnant lupus patients continue taking it because:

• Stopping during pregnancy increases the risk of flares
• Flares during pregnancy carry significant risks for both mother and baby
• Studies show no increased risk of birth defects
• It may reduce the risk of neonatal lupus and congenital heart block in babies born to mothers with anti-Ro/SSA antibodies

If you are planning a pregnancy, talk to your rheumatologist about your medication plan — but do not stop hydroxychloroquine on your own.

What the Latest Research Shows

Several key findings have reinforced hydroxychloroquine's role in 2026:

• Flare prevention remains robust — patients who stay on hydroxychloroquine long-term have significantly fewer flares than those who discontinue
• Cardiovascular protection — growing evidence suggests it reduces the risk of heart disease in lupus patients, which is important because cardiovascular disease is a leading cause of death in SLE
• Blood sugar benefits — some studies indicate it may improve insulin sensitivity, which is relevant for patients on long-term corticosteroids
• COVID-era clarity — the pandemic-era hype around hydroxychloroquine for COVID-19 has fully settled, and supply chain issues that once affected lupus patients are resolved

Common Side Effects

Most patients tolerate hydroxychloroquine well, but you may experience:

• Nausea or stomach upset — taking it with food usually helps
• Skin reactions — rare, but possible
• Headaches — usually temporary when first starting

These are generally mild and often improve with time.

The Bottom Line: Do Not Stop Taking It

The single most important message about hydroxychloroquine is this: do not stop taking it without talking to your doctor, even when you feel well. Many patients make the mistake of thinking they no longer need it once their symptoms improve. But the research consistently shows that discontinuation leads to more flares, more organ damage, and worse long-term outcomes.

Hydroxychloroquine works best as a long-term, foundational treatment. Think of it as the base layer of your lupus management strategy.

Tracking Your Medication With Lycana

Staying consistent with hydroxychloroquine is easier when you can see the connection between adherence and how you feel. Lycana lets you log your medications daily and track symptoms alongside them, helping you and your rheumatologist spot patterns over time — like whether missed doses correlate with increased symptoms weeks later.

---

This article is for informational purposes only and is not medical advice. Always consult your rheumatologist or healthcare provider before making changes to your medication regimen.